Analyzing the Market Sentiment for CTVA

This morning we watched Corteva drop -2.5% to a price of $54.27 per share. The Large-Cap Farming company is now trading -14.82% below its average target price of $63.71. Analysts have set target prices ranging from $54.0 to $69.0 per share for Corteva, and have given the stock an average rating of buy.

The stock has a very low short interest at 1.4%, and a short ratio of 2.63. At 0.08%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that a significant number of institutional investors are invested in the stock, with 84.0% of Corteva's shares being owned by this investor type.

Institutions Invested in Corteva

Date Reported Holder Percentage Shares Value
2024-03-31 Vanguard Group Inc 11% 79,847,622 $4,333,330,482
2024-03-31 Blackrock Inc. 8% 53,585,643 $2,908,092,870
2024-03-31 State Street Corporation 5% 32,446,602 $1,760,877,105
2024-03-31 Capital International Investors 4% 26,437,457 $1,434,760,803
2024-03-31 Aristotle Capital Management, LLC 4% 24,744,282 $1,342,872,195
2024-03-31 Geode Capital Management, LLC 2% 15,902,519 $863,029,713
2024-03-31 Independent Franchise Partners, LLP 2% 14,423,081 $782,740,612
2024-03-31 Nuveen Asset Management, LLC 2% 13,460,040 $730,476,376
2024-03-31 Massachusetts Financial Services Co. 2% 13,019,192 $706,551,555
2024-03-31 Morgan Stanley 2% 12,827,664 $696,157,331

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Corteva.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.